default author photo

Katsumi Nakatomi

National Hospital Organization Ureshino Medical Center

SCHOLARLY PAPERS

3

DOWNLOADS

84

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

Pemetrexed Plus Platinum as Second-Line Treatment for Patients with Pleural Mesothelioma Treated with Nivolumab Plus Ipilimumab

Number of pages: 26 Posted: 08 Apr 2025
affiliation not provided to SSRN, Nagasaki University, University of Occupational and Environmental Health, University of Occupational and Environmental Health, Osaka City General Hospital, Fujita Health University, Hokkaido University, affiliation not provided to SSRN, Saga University, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of the Ryukyus, affiliation not provided to SSRN, Fukuoka University Chikushi Hospital, Kanazawa Medical University, National Hospital Organization Ureshino Medical Center, affiliation not provided to SSRN, affiliation not provided to SSRN, Nagasaki University and Nagasaki University - Department of Respiratory Medicine
Downloads 33 (1,277,121)

Abstract:

Loading...

Mesothelioma, Chemotherapy, Pemetrexed, Platinum, Second-line

2.

Phase I study of amrubicin plus cisplatin and concurrent accelerated hyperfractionated thoracic radiotherapy for limited-stage small cell lung cancer

Number of pages: 22 Posted: 17 Dec 2025
National Cancer Center Research Institute, Nagasaki University, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Sasebo City General Hospital, affiliation not provided to SSRN, Sasebo City General Hospital, affiliation not provided to SSRN, Nagasaki University, affiliation not provided to SSRN, Nagasaki University, Sasebo City General Hospital, Nagasaki University, Nagasaki University, Nagasaki University, Sasebo City General Hospital, Nagasaki University, Sasebo City General Hospital, Sasebo City General Hospital, affiliation not provided to SSRN, affiliation not provided to SSRN, Nagasaki University - Nagasaki University Hospital, Nagasaki University - Nagasaki University Hospital, affiliation not provided to SSRN, National Hospital Organization Ureshino Medical Center, affiliation not provided to SSRN, affiliation not provided to SSRN, Nagasaki University - Nagasaki University Hospital, Nagasaki University - Nagasaki University Hospital and Nagasaki University - Department of Respiratory Medicine
Downloads 32 (1,290,922)

Abstract:

Loading...

Limited-stage, Small Cell Lung Cancer, Amrubicin, Cisplatin, Accelerated, Hyperfractionated, radiotherapy

3.

Mechanisms of Resistance and Correlation between Pre-Treatment Co-Alterations and Prognosis to Osimertinib in Chemo-Naïve Advanced Non-Small Cell Lung Cancer

Number of pages: 34 Posted: 12 Jun 2024
Kinki-chuo Chest Medical Center, Wakayama Medical University, Shikoku Cancer Centre, Kinki-chuo Chest Medical Center, Kinki-chuo Chest Medical Center, Asahikawa Medical University, National Hospital Organization Himeji Medical Center, National Hospital Organization Kochi Hospital, National Hospital Organization (NHO) - Mito Medical Center, National Hospital Organization Ureshino Medical Center, National Hospital Organization Nagoya Medical Center, National Hospital Organization (NHO) - Osaka Toneyama Medical Center, National Hospital Organization Shibukawa Medical Center, Nagoya University - Department of Advanced Medicine, National Hospital Organization Kyushu Medical Center, National Hospital Organization (NHO) - Department of Respiratory Diseases and Wakayama Medical University
Downloads 19 (1,459,862)

Abstract:

Loading...

osimertinib, non-small cell lung cancer, epidermal growth factor receptor, resistance mechanism, circulating tumour DNA